Delivery Order SPE2DB25D7067-SPE2DB25FSULX

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $15,129.35 and runs until July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This is a delivery order valued at $2,216.07 awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to support military healthcare programs. The contract has a final completion date of February 5, 2025 and is a firm fixed price arrangement. There is no set-aside designation indicated. Amerisourcebergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,732.78 contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM and has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.17 contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The award has an ultimate completion date of January 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,525.66, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,625.48 firm fixed-price contract is for the delivery of an ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical product. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM. The contract has a ceiling value of $5,708.49 and a completion date of January 4, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,641.58, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,837.87 firm fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 8, 2024. This delivery order is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4563237224 ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a ceiling value of $1,630.67 and an ultimate completion date of January 5, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSULX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The contract has a firm fixed price of $2,403.52 and a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 10:21 AM